Management of infected stone disease with hydroxyurea: a five year follow-up.

Management of infected stone disease with hydroxyurea: a five year follow-up. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Management of infected stone disease with hydroxyurea: a five year follow-up. Abstract Text:

M J Smith,

Hydroxyurea in a morning dose of 500 mg along with Macrodantin, 100 mg, has been used for more than five years as an adjunct to the management of retained struvite stones. Mild reversible toxicity occurs in 10 per cent. Urine sterility can be achieved in ninety per cent and no growth of the retained stone occurs.

Management of infected stone disease with hydroxyurea: a five year follow-up. Publishing Authors By Initials

MJ Smith,

For similar bacterial infections and mycoses: infection: urinary tract infections research abstracts see: bacterial infections and mycoses: infection: urinary tract infections research

PUBMED ID PMID:

MEDLINE DATE:

Management of infected stone disease with hydroxyurea: a five year follow-up. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Proceedings of the European Dialysis and Transplan

VOLUME: 20

Page Numbers: 466-8

Journal Abbreviation:

ISSN: 0071-2736

DAY: 21

MONTH: 02

YEAR: 1983

Management of infected stone disease with hydroxyurea: a five year follow-up. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 355210

Management of infected stone disease with hydroxyurea: a five year follow-up. Keywords Mesh Terms:

KEYWORDS: Urinary Tract Infections

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Management of infected stone disease with hydroxyurea: a five year follow-up. Information

Substance Name: Hydroxyurea

Registry Number: 127-07-1

Grant and Affiliation Information for Management of infected stone disease with hydroxyurea: a five year follow-up.

AFFILIATION:

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Proc Eur Dial Transplant Assoc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Management of infected stone disease with hydroxyurea: a five year follow-up Related Publications

• 10 do's and don'ts about tax homes.
• A gravitational lens.
• An animal evaluation of a paste of chitosan glutamate and hydroxyapatite as a synthetic bone graft material.
• An electrostrictive drive for fine pitch control in double-crystal monochromators.
• Animal model of human disease: inherited erythrocyte glutathione deficiency.
• Bacterial pathogens of the respiratory tract of the newborn infant.
• Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin.
• Calculating Society's Willingness to Pay for a QALY : Key Questions for Discussion.
• Characterizing the structures and folding of free proteins using 2-D gas-phase separations: observation of multiple unfolded conformers.
• Coccidioidomycosis.
• Demoralization, anhedonia and grief in patients with severe physical illness.
• Developmental outcomes after early or delayed insertion of tympanostomy tubes.
• Effects of hormone-induced superovulation on latent infectious bovine rhinotracheitis virus in cattle.
• Euphemistic codes and tell-tale hearts: humane assistance in end-of-life cases.
• Evaluation of beta-endorphin and naloxone on bovine uterine motility.
• Gastrointestinal disease in adolescents.
• Increased amyloid- levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet.
• Joys of teaching nursing.
• Occupational health in India.
• Odontoblast morphology and dental repair.
• Practical management of tuberculosis.
• Preventing and treating: Heart disease in women.
• Synthesis of 4,4-difluoroglycosides using ring-closing metathesis.
• The Herpesvirus capsid surface protein, VP26, and the majority of the tegument proteins are dispensable for capsid transport toward the nucleus.
• The effects of rhBMP-2 on human osteosarcoma cells and human gingival fibroblasts in vitro.
• The effects of xylazine hydrochloride on intrauterine pressure in the cow.
• The reliability of willingness to pay for changes in health status.
• The role of primary care in infertility management.
• What is happening in the real world in lipid therapy and is it appropriate? The need for a paradigm shift.
• X-ray Imaging and Microspectroscopy of Plants and Fungi.